搜索临床试验以：Neoadjuvant Teriprizumab in Combination With Gemcitabine and Cisplatin
总计452个结果
-
Pfizer终止
-
AHS Cancer Control AlbertaCelgene主动，不招人
-
Cyteir Therapeutics, Inc.主动，不招人软组织肉瘤 | 滤泡性淋巴瘤 | 乳腺癌 | 头颈癌 | 小细胞肺癌 | 多发性骨髓瘤 | 胰腺癌 | 卵巢癌 | 套细胞淋巴瘤 | 头颈部鳞状细胞癌 | 三阴性乳腺癌 | DLBCL | 非霍奇金淋巴瘤 | 恶性肿瘤 | 慢性淋巴细胞白血病美国
-
National University Hospital, SingaporeNational Cancer Centre, Singapore未知
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
University of Alabama at BirminghamEli Lilly and Company完全的
-
Second Affiliated Hospital, School of Medicine,...主动，不招人
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019.完全的
-
Professor Fernando Figueira Integral Medicine InstituteInstituto Nacional de Cancer, Brazil完全的
-
National University Hospital, Singapore完全的
-
Leiden University Medical Center招聘中
-
Shanghai Junshi Bioscience Co., Ltd.招聘中
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
Eye & ENT Hospital of Fudan UniversityChanghai Hospital; Shanghai Zhongshan Hospital; Fujian Medical University Union Hospital; Shenzhen... 和其他合作者尚未招聘
-
Treace Medical Concepts, Inc.招聘中
-
AstraZeneca招聘中
-
Cytos Biotechnology AG完全的
-
Acerta Pharma BVAstraZeneca主动，不招人
-
The First Affiliated Hospital with Nanjing Medical...未知
-
Yunnan Cancer HospitalBeijing Bethune Charitable Foundation招聘中
-
University of Alabama at Birmingham主动，不招人